Table 2.
Histopathology | BC (n = 72)a | BBL (n = 15)a |
---|---|---|
Carcinoma in situ | 3 (4.2%) | |
Invasive duct carcinoma | 54 (75%) | |
Mammary carcinoma | 8 (11.1%) | |
Metaplastic carcinoma | 4 (5.6%) | |
Invasive lobular carcinoma | 1 (1.4%) | |
Neoplastic multifocal carcinoma | 1 (1.4%) | |
Papillary intraductal carcinoma | 1 (1.4%) | |
Benign mammary lesion | 4 (26.6%) | |
Fibroadenoma | 3 (20%) | |
Fibrocystic changes | 1 (6.66%) | |
Benign ductal epithelial cells | 1 (6.66%) | |
Benign mastitis | 1 (6.66%) | |
Benign unspecified | 5 (33.3%) |
Abbreviations: BBL, benign breast lesions; BC, breast cancer.
Numbers in parenthesis represent the percent.